These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7580745)

  • 21. [Clinical testing of a new benzodiazepine, bromazepam, in a double blind test with thioridazine].
    Mironi F; Saccardo M; Lion P
    Riv Neurobiol; 1972; 18(3-4):257-66. PubMed ID: 4157046
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapy of neurotic and pseudoneurotic symptoms with tofisopam.
    Libus J; Libusova E
    Agressologie; 1981 Nov; 22(D):21-2. PubMed ID: 6120662
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clobazam (Frisium) in everyday practice. An open six-months' study of its efficacy and tolerance (author's transl)].
    Radmayr E; Koeppen D
    MMW Munch Med Wochenschr; 1977 Dec; 119(50):1623-6. PubMed ID: 23493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Autonomic effect of grandaxin in the treatment of neurotic disorders in general somatic practice (lecture)].
    Aleksandrovskiĭ IuA; Avedisova AS; Pavlova MS
    Ter Arkh; 1998; 70(10):76-8. PubMed ID: 9864811
    [No Abstract]   [Full Text] [Related]  

  • 25. The psychosedative effect of chlordesmethyldiazepam on anxiety states in neurotic and psychotic inpatients.
    Paradiso L; Rapisarda V
    Clin Ther; 1980; 3(3):194-9. PubMed ID: 6109567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relation between the dynamics of EEG indices after a single dose of the tranquilizer phenazepam and its efficacy during a course of treatment of patients with borderline neuropsychological disorders].
    Uvarova LG; Titaeva MA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(11):1701-9. PubMed ID: 4082841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of signopam in the complex treatment of patients with mental disorders].
    Voronkov GL; Poliachenko AB
    Vrach Delo; 1988 Apr; (4):105-6. PubMed ID: 2899930
    [No Abstract]   [Full Text] [Related]  

  • 28. [General and particular clinical effects of tranquilizers].
    Aleksandrovskiĭ IuA
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():67-76. PubMed ID: 22888
    [No Abstract]   [Full Text] [Related]  

  • 29. Does chlordesmethyldiazepam have a specific anti-erotic effect? Report on five observations.
    Cocchi R; Passanisi S; Macci F
    Acta Psychiatr Belg; 1982; 82(6):555-64. PubMed ID: 6134427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Is it possible to predict individual stress resistance by evaluating low dose benzodiazepine effect in modeled emotional stress].
    Seredenin SB; Badyshtov BA; Neznamov GG; Kolotilinskaia NV; Makhnycheva AL; Nadorov SA
    Eksp Klin Farmakol; 2001; 64(2):3-10. PubMed ID: 11548443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot open-label study on U-31,889 in anxious in-patients.
    Fabre LF; Harris RT
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):1010-3. PubMed ID: 4154181
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of phenazepam in the treatment of neurotic conditions].
    Dubnitskaia EB; Basov AM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(9):1382-6. PubMed ID: 30245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical study of a new tranquilizer, Lexotan, in neurotic disorders].
    De Geyter J; Dumont E; Stenier P
    Sem Hop Ther; 1975 Apr; 51(4):247-52. PubMed ID: 5776
    [No Abstract]   [Full Text] [Related]  

  • 34. [Correlation between the experimental and clinical effectiveness of benzodiazepines and their affinity for benzodiazepine receptors].
    Rudenko GM; Voronina TA; Shatrova NG; Chepelev VM
    Biull Eksp Biol Med; 1982 Aug; 94(8):54-6. PubMed ID: 6127125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Profiles of regular consumers of benzodiazepines in a family practice].
    Lagro-Janssen AL; Liberton IJ
    Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1969-73. PubMed ID: 8105394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of narrow frequency bands of the EEG spectrum for demonstrating the effect of diazepam in patients with borderline mental disorders].
    Bochkarev VK; Serebriakova TV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(10):73-7. PubMed ID: 1665660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical investigations of some anxiolytics drugs.
    Welbel SL
    Agressologie; 1981 Oct; 22(C):39-40. PubMed ID: 6119919
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes in the antioxidative activity and phospholipid composition of the erythrocytes in neurosis patients as affected by fenazepam].
    Kaipova GD; Burlakova EB; Molochkina EM; Neznamov GG; Poiurovskiĭ MV
    Biull Eksp Biol Med; 1988 Feb; 105(2):171-3. PubMed ID: 3349146
    [No Abstract]   [Full Text] [Related]  

  • 39. Observations with tofisopam (grandaxin) treatment in children's diseases.
    Szórády I; Borsodi A
    Ther Hung; 1983; 31(4):172-5. PubMed ID: 6152818
    [No Abstract]   [Full Text] [Related]  

  • 40. Pilot open label study with alprazolam (U31, 889) in outpatients with neurotic depression.
    Fabre LF
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):661-8. PubMed ID: 6216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.